Prolonged survival after neoadjuvant chemotherapy related with specific molecular alterations in the patients with nonsmall-cell lung carcinoma.
Stojsic, Jelena
Prolonged survival after neoadjuvant chemotherapy related with specific molecular alterations in the patients with nonsmall-cell lung carcinoma. [electronic resource] - Experimental and molecular pathology Feb 2015 - 27-32 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1096-0945
10.1016/j.yexmp.2014.11.010 doi
Adenocarcinoma--drug therapy
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers, Tumor--metabolism
Carcinoma, Non-Small-Cell Lung--drug therapy
Carcinoma, Squamous Cell--drug therapy
Female
Follow-Up Studies
Gene Expression Regulation, Neoplastic
Humans
Immunoenzyme Techniques
Loss of Heterozygosity
Lung Neoplasms--drug therapy
Male
Middle Aged
Neoadjuvant Therapy
Neoplasm Grading
Neoplasm Invasiveness
Neoplasm Staging
PTEN Phosphohydrolase--genetics
Phosphatidylinositol 3-Kinases--metabolism
Polymerase Chain Reaction
Prognosis
Proto-Oncogene Proteins c-akt--metabolism
Signal Transduction
Survival Rate
TOR Serine-Threonine Kinases--metabolism
Prolonged survival after neoadjuvant chemotherapy related with specific molecular alterations in the patients with nonsmall-cell lung carcinoma. [electronic resource] - Experimental and molecular pathology Feb 2015 - 27-32 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1096-0945
10.1016/j.yexmp.2014.11.010 doi
Adenocarcinoma--drug therapy
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers, Tumor--metabolism
Carcinoma, Non-Small-Cell Lung--drug therapy
Carcinoma, Squamous Cell--drug therapy
Female
Follow-Up Studies
Gene Expression Regulation, Neoplastic
Humans
Immunoenzyme Techniques
Loss of Heterozygosity
Lung Neoplasms--drug therapy
Male
Middle Aged
Neoadjuvant Therapy
Neoplasm Grading
Neoplasm Invasiveness
Neoplasm Staging
PTEN Phosphohydrolase--genetics
Phosphatidylinositol 3-Kinases--metabolism
Polymerase Chain Reaction
Prognosis
Proto-Oncogene Proteins c-akt--metabolism
Signal Transduction
Survival Rate
TOR Serine-Threonine Kinases--metabolism